9535 related articles for article (PubMed ID: 11593666)
1. [The effects on melanoma and immunological mechanism of human interferon-alpha gene therapy by fibroblasts].
Chen M; Lin Z; Cao X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Sep; 16(5):298-301. PubMed ID: 11593666
[TBL] [Abstract][Full Text] [Related]
2. [Immunological mechanism of human alpha-interferon gene therapy for treatment of melonoma].
Chen M; Lin Z; Cao X
Zhonghua Zheng Xing Wai Ke Za Zhi; 2001 Sep; 17(5):306-8. PubMed ID: 11767713
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study on the treatment of human hepatocellular carcinoma by fibroblast-mediated human IFN-alpha gene therapy in combination with adoptive chemoimmunotherapy].
Wang J; Cao X; Kong X
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):266-70. PubMed ID: 7587892
[TBL] [Abstract][Full Text] [Related]
4. Implantation of genetically manipulated fibroblasts into mice as antitumor alpha-interferon therapy.
Ogura H; Tani K; Ozawa K; Nagata S; Asano S; Takaku F
Cancer Res; 1990 Aug; 50(16):5102-6. PubMed ID: 2165855
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and antitumor effect following im electroporation delivery of human interferon alpha 2 gene.
Zhang GH; Tan XF; Shen D; Zhao SY; Shi YL; Jin CK; Sun WG; Guo YH; Chen KH; Tang J
Acta Pharmacol Sin; 2003 Sep; 24(9):891-6. PubMed ID: 12956937
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
8. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.
Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR
J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346
[TBL] [Abstract][Full Text] [Related]
9. Efficient human interferon-alpha gene transfer to neuroendocrine tumor cells with long-term and stable expression.
Liu M; Kilarski WW; Gerwins P; Oberg K; Zhou Y
Neuroendocrinology; 2005; 82(5-6):264-73. PubMed ID: 16721032
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
11. [Implantation of genetically manipulated fibroblasts into mice as a model of gene therapy--supplementations of human granulocyte colony-stimulating factor (hG-CSF) and interferon-alpha (IFN-alpha)].
Tani K
Hum Cell; 1991 Mar; 4(1):25-32. PubMed ID: 1653596
[TBL] [Abstract][Full Text] [Related]
12. Treatment of leukemia with fibroblast-mediated interferon-alpha gene therapy alone or in combination with doxorubicin.
Wang J; Cao X; Zhang W; Ye T; Tani K
Leuk Res; 1996 May; 20(5):379-84. PubMed ID: 8683976
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors.
Indraccolo S; Moserle L; Tisato V; Gola E; Minuzzo S; Roni V; Persano L; Chieco-Bianchi L; Amadori A
Gene Ther; 2006 Jun; 13(12):953-65. PubMed ID: 16511522
[TBL] [Abstract][Full Text] [Related]
15. [Induction and mechanism study of anti-melanoma immune response by M. tuberculosis Ag85B].
Wu XZ; Wei HM; Zheng XD; Jin TC; Tian ZG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):36-8. PubMed ID: 17210103
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene.
Scarpa S; Giuffrida A; Palumbo C; Vasaturo F; Signorelli P; Forni G; Modesti M; Ferrantini M; Belardelli F; Musiani P; Modesti A
J Pathol; 1997 Jan; 181(1):116-23. PubMed ID: 9072013
[TBL] [Abstract][Full Text] [Related]
17. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
Miyake K; Tsuchida K; Sugino H; Imura S; Morine Y; Fujii M; Shimada M
Cancer Chemother Pharmacol; 2007 Jan; 59(1):113-26. PubMed ID: 16699793
[TBL] [Abstract][Full Text] [Related]
19. [Experimental studies on inhibition of malignant melanoma growth by gene transfer of adenovirus-mediated averse vascular endothelial growth factor165].
Cui Z; Cen Y; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 May; 20(5):499-503. PubMed ID: 16752833
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
